Emerging Therapies for Malignant Mesothelioma
van Zandwijk, Nico
Emerging Therapies for Malignant Mesothelioma - Frontiers Media SA 2020 - 1 electronic resource (114 p.)
Open Access
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
Creative Commons
English
978-2-88963-873-4 9782889638734
10.3389/978-2-88963-873-4 doi
Medicine
Oncology
malignant mesothelioma tumor biology preclinical models immune environment angiogenesis inhibitors chemotherapy immunotherapy microRNA
Emerging Therapies for Malignant Mesothelioma - Frontiers Media SA 2020 - 1 electronic resource (114 p.)
Open Access
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
Creative Commons
English
978-2-88963-873-4 9782889638734
10.3389/978-2-88963-873-4 doi
Medicine
Oncology
malignant mesothelioma tumor biology preclinical models immune environment angiogenesis inhibitors chemotherapy immunotherapy microRNA